Macrogenics reported $15.35M in Selling and Administration Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US USD 3.3B 174M
Amgen AMGN:US USD 1.29B 40M
AstraZeneca AZN:LN USD 3.35B 280M
Biogen BIIB:US USD 563.3M 9.3M
Bristol Myers Squibb BMY:US USD 1.93B 147M
Daiichi Sankyo 4568:JP JPY 113.49B 17.11B
Eli Lilly And LLY:US USD 1.61B 10.9M
Genmab GEN:DC DKK 670M 37M
Geron GERN:US USD 15.64M 8.2M
Gilead Sciences GILD:US USD 1.21B 144M
Immunogen IMGN:US USD 33.62M 9.83M
Johnson & Johnson JNJ:US USD 6.09B 137M
Karyopharm Therapeutics KPTI:US USD 34.64M 2.69M
Macrogenics MGNX:US USD 15.35M 1.69M
Merk MRK:US USD 2.47B 13M
Mirati Therapeutics MRTX:US USD 60.8M 6.57M
Pfizer PFE:US USD 3.54B 345M
Puma Biotechnology PBYI:US USD 23.96M 3.38M
Regeneron Pharmaceuticals REGN:US USD 529.1M 52.8M
Seattle Genetics SGEN:US USD 210.38M 9.88M
Xencor XNCR:US USD 12.37M 1.28M